IMU Biosciences
Inga D. is a seasoned investment professional specializing in Healthtech and Life Sciences across the UK and Europe, currently serving as Principal at Molten Ventures since November 2020. Inga has held significant roles, including Director positions at Deciphex, Anima, IMU Biosciences, Oliva, and Aktiia, where notable fundraising efforts include leading multiple Series A and C rounds totaling over €65 million. Prior experience includes an Entrepreneur In Residence role at Duke University, focusing on medical devices and healthtech commercialization, and a Chief of Staff position at Inivata Limited, which was acquired for $390 million. Inga's educational background includes a DPhil PhD in Neuroscience from the University of Oxford and a Navigating Healthcare Trends Certificate from Duke University.
This person is not in any teams
This person is not in any offices
IMU Biosciences
1 followers
Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics.